Atlas Trials

AUY922 for Advanced ALK-positive NSCLC

Clinical trial NCT01752400 · COMPLETED

Trial details

NCT number
NCT01752400
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2013-01-01
Primary completion
2017-06-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.